Cargando…

Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali

BACKGROUND: Koulikoro Health District is one of three districts of Mali where the indoor residual spray (IRS) has been implemented from 2008 to 2016. With widespread of resistance to pyrethroid, IRS was shifted from pyrethroid to pirimiphos-methyl from 2014 to 2016. The objective of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kané, Fousseyni, Keïta, Moussa, Traoré, Boïssé, Diawara, Sory Ibrahim, Bane, Sidy, Diarra, Souleymane, Sogoba, Nafomon, Doumbia, Seydou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425591/
https://www.ncbi.nlm.nih.gov/pubmed/32787938
http://dx.doi.org/10.1186/s12936-020-03357-8
_version_ 1783570526204067840
author Kané, Fousseyni
Keïta, Moussa
Traoré, Boïssé
Diawara, Sory Ibrahim
Bane, Sidy
Diarra, Souleymane
Sogoba, Nafomon
Doumbia, Seydou
author_facet Kané, Fousseyni
Keïta, Moussa
Traoré, Boïssé
Diawara, Sory Ibrahim
Bane, Sidy
Diarra, Souleymane
Sogoba, Nafomon
Doumbia, Seydou
author_sort Kané, Fousseyni
collection PubMed
description BACKGROUND: Koulikoro Health District is one of three districts of Mali where the indoor residual spray (IRS) has been implemented from 2008 to 2016. With widespread of resistance to pyrethroid, IRS was shifted from pyrethroid to pirimiphos-methyl from 2014 to 2016. The objective of this study was to assess the added value of IRS to LLINs on the prevalence of parasitaemia and malaria incidence among children under 10 years old. METHODS: A comparative study was carried out to assess the effects of pirimiphos-methyl based IRS on malaria prevalence and incidence among children from 6 months to 10 years old in selected pyrethroid resistance villages of two health districts in Mali: one where IRS was implemented in combination with LLINs (intervention area) and one with LLINs-only (control area). Two cross-sectional surveys were carried out at the beginning (June) and end of the rainy season (October) to assess seasonal changes in malaria parasitaemia by microscopy. A passive detection case (PCD) was set-up in each study village for 9 months to estimate the incidence of malaria using RDT. RESULTS: There was an increase of 220% in malaria prevalence from June to October in the control area (14% to 42%) versus only 53% in the IRS area (9.2% to 13.2%). Thus, the proportional rise in malaria prevalence from the dry to the rainy season in 2016 was 4-times greater in the control area compared to the IRS area. The overall malaria incidence rate was 2.7 per 100 person-months in the IRS area compared with 6.8 per 100 person-month in the control areas. The Log-rank test of Kaplan–Meier survival analysis showed that children living in IRS area remain much longer free from malaria (Hazard ratio (HR) = 0.45, CI 95% 0.37–0.54) than children of the control area (P < 0.0001). CONCLUSIONS: IRS using pirimiphos-methyl has been successful in reducing substantially both the prevalence and the incidence of malaria in children under 10 years old in the area of pyrethroid resistance of Koulikoro, Mali. Pirimiphos-methyl is a better alternative than pyrethroids for IRS in areas with widespread of pyrethroid resistance.
format Online
Article
Text
id pubmed-7425591
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74255912020-08-16 Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali Kané, Fousseyni Keïta, Moussa Traoré, Boïssé Diawara, Sory Ibrahim Bane, Sidy Diarra, Souleymane Sogoba, Nafomon Doumbia, Seydou Malar J Research BACKGROUND: Koulikoro Health District is one of three districts of Mali where the indoor residual spray (IRS) has been implemented from 2008 to 2016. With widespread of resistance to pyrethroid, IRS was shifted from pyrethroid to pirimiphos-methyl from 2014 to 2016. The objective of this study was to assess the added value of IRS to LLINs on the prevalence of parasitaemia and malaria incidence among children under 10 years old. METHODS: A comparative study was carried out to assess the effects of pirimiphos-methyl based IRS on malaria prevalence and incidence among children from 6 months to 10 years old in selected pyrethroid resistance villages of two health districts in Mali: one where IRS was implemented in combination with LLINs (intervention area) and one with LLINs-only (control area). Two cross-sectional surveys were carried out at the beginning (June) and end of the rainy season (October) to assess seasonal changes in malaria parasitaemia by microscopy. A passive detection case (PCD) was set-up in each study village for 9 months to estimate the incidence of malaria using RDT. RESULTS: There was an increase of 220% in malaria prevalence from June to October in the control area (14% to 42%) versus only 53% in the IRS area (9.2% to 13.2%). Thus, the proportional rise in malaria prevalence from the dry to the rainy season in 2016 was 4-times greater in the control area compared to the IRS area. The overall malaria incidence rate was 2.7 per 100 person-months in the IRS area compared with 6.8 per 100 person-month in the control areas. The Log-rank test of Kaplan–Meier survival analysis showed that children living in IRS area remain much longer free from malaria (Hazard ratio (HR) = 0.45, CI 95% 0.37–0.54) than children of the control area (P < 0.0001). CONCLUSIONS: IRS using pirimiphos-methyl has been successful in reducing substantially both the prevalence and the incidence of malaria in children under 10 years old in the area of pyrethroid resistance of Koulikoro, Mali. Pirimiphos-methyl is a better alternative than pyrethroids for IRS in areas with widespread of pyrethroid resistance. BioMed Central 2020-08-12 /pmc/articles/PMC7425591/ /pubmed/32787938 http://dx.doi.org/10.1186/s12936-020-03357-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kané, Fousseyni
Keïta, Moussa
Traoré, Boïssé
Diawara, Sory Ibrahim
Bane, Sidy
Diarra, Souleymane
Sogoba, Nafomon
Doumbia, Seydou
Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title_full Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title_fullStr Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title_full_unstemmed Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title_short Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali
title_sort performance of irs on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in koulikoro region, mali
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425591/
https://www.ncbi.nlm.nih.gov/pubmed/32787938
http://dx.doi.org/10.1186/s12936-020-03357-8
work_keys_str_mv AT kanefousseyni performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT keitamoussa performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT traoreboisse performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT diawarasoryibrahim performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT banesidy performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT diarrasouleymane performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT sogobanafomon performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali
AT doumbiaseydou performanceofirsonmalariaprevalenceandincidenceusingpirimiphosmethylinthecontextofpyrethroidresistanceinkoulikororegionmali